Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 12:57 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BANK OF AMERICA CORP BAC | 1,811,206 7.6% | 1,811,206 (New Position) | View |
| 2020-02-12 10:43 am Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | DIMENSIONAL FUND ADVISORS LP | 1,209,001 5.07% | 1,209,001 (New Position) | View |
| 2020-02-10 2:19 pm Sale | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BlackRock Inc. BLK | 1,468,959 4.96% | -37,695 (-2.50%) | View |
| 2020-02-06 1:34 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | Arkin Moshe | 1,572,394 5.5% | 1,572,394 (New Position) | View |
| 2020-02-05 11:26 am Sale | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BlackRock Inc. BLK | 1,506,654 6.3% | -193,831 (-11.40%) | View |
| 2020-01-23 2:21 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | INGALLS & SNYDER LLC | 1,464,712 6.1% | 264,937 (+22.08%) | View |
| 2019-07-03 3:31 pm Sale | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | BIOTECHNOLOGY VALUE FUND L P | 1,408,187 5.9% | -1,377,300 (-49.45%) | View |